Pten constrains centroacinar cell expansion and malignant transformation in the pancreas.

[1]  M. Callery,et al.  PI-3’ kinase and NF-ΚB cross-signaling in human pancreatic cancer cells , 2001, Journal of Gastrointestinal Surgery.

[2]  Yixin Yao,et al.  The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells , 2005, Oncogene.

[3]  Michio Shimizu,et al.  An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms , 2004, The American journal of surgical pathology.

[4]  L. Chin,et al.  High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Douglas A. Melton,et al.  Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation , 2004, Nature.

[6]  S. Leach.  Mouse models of pancreatic cancer: the fur is finally flying! , 2004, Cancer cell.

[7]  R. DePinho,et al.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.

[8]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[9]  D. Melton,et al.  Notch signaling controls multiple steps of pancreatic differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Beckett,et al.  Incidence, mechanism and prognostic value of activated AKT in pancreas cancer , 2003, British Journal of Cancer.

[11]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[12]  L. Cantley,et al.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.

[13]  J. Hald,et al.  Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. , 2003, Developmental biology.

[14]  M. Imamura,et al.  Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. , 2003, Surgery.

[15]  R. Hruban,et al.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.

[16]  H. Friess,et al.  Origin and Development of the Precursor Lesions in Experimental Pancreatic Cancer in Rats , 2003, Laboratory Investigation.

[17]  Hong Wu,et al.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.

[18]  S. Batra,et al.  What is the origin of pancreatic adenocarcinoma? , 2003, Molecular Cancer.

[19]  G. Mills,et al.  Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. , 2002, Molecular cancer therapeutics.

[20]  Scott E Kern,et al.  Focus on pancreas cancer. , 2002, Cancer cell.

[21]  R. Schmid.  Acinar-to-ductal metaplasia in pancreatic cancer development. , 2002, The Journal of clinical investigation.

[22]  D. Melton,et al.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.

[23]  David Tosh,et al.  How cells change their phenotype , 2002, Nature Reviews Molecular Cell Biology.

[24]  P. Malfertheiner,et al.  Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1 , 2002, British Journal of Cancer.

[25]  M. Loda,et al.  Obligate Roles for p16Ink4a and p19Arf-p53 in the Suppression of Murine Pancreatic Neoplasia , 2002, Molecular and Cellular Biology.

[26]  J. Testa,et al.  Frequent activation of AKT2 kinase in human pancreatic carcinomas , 2002, Journal of cellular biochemistry.

[27]  T. Jacks,et al.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.

[28]  A. Trumpp,et al.  Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo , 2001, Science.

[29]  S. Leach,et al.  Developmental aspects of early pancreatic cancer. , 2001, Cancer journal.

[30]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[31]  T. Mattfeldt,et al.  A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. , 2001, Genes & development.

[32]  Caiying Guo,et al.  Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon cre‐mediated excision , 2000, Genesis.

[33]  P Komminoth,et al.  Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. , 2000, The American journal of pathology.

[34]  S. Leach,et al.  p53-dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[35]  F. Vittimberga,et al.  Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent. , 2000, The Journal of surgical research.

[36]  M. Washington,et al.  Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. , 1999, Gastroenterology.

[37]  C. Lobe,et al.  Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.

[38]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[39]  R. Schmid,et al.  Acinar-ductal-carcinoma sequence in transforming growth factor-alpha transgenic mice. , 1999, Annals of the New York Academy of Sciences.

[40]  A. McMahon,et al.  Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase , 1998, Current Biology.

[41]  R. Schmid,et al.  Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. , 1998, Gastroenterology.

[42]  G. Riggins,et al.  Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. , 1998, Cancer research.

[43]  J. Cheng,et al.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.

[44]  T. Ono,et al.  Infrequent Genetic Alterations of the PTEN/MMAC1 Gene in Japanese Patients with Primary Cancers of the Breast, Lung, Pancreas, Kidney, and Ovary , 1997, Japanese journal of cancer research : Gann.

[45]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Hogan,et al.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.

[47]  R. Hruban,et al.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.

[48]  H. Edlund,et al.  Insulin-promoter-factor 1 is required for pancreas development in mice , 1994, Nature.

[49]  D. Hanahan,et al.  Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. , 1994, The American journal of pathology.

[50]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[51]  G. Merlino,et al.  TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.

[52]  R. Palmiter,et al.  Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.

[53]  R. Hammer,et al.  Differential requirements for cell-specific elastase I enhancer domains in transfected cells and transgenic mice. , 1989, Genes & development.

[54]  R. Palmiter,et al.  Promoter and enhancer elements from the rat elastase I gene function independently of each other and of heterologous enhancers , 1987, Molecular and cellular biology.

[55]  P. Pour,et al.  Ductal metaplasia of human exocrine pancreas and its association with carcinoma. , 1985, Cancer research.

[56]  A. Cubilla,et al.  Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. , 1976, Cancer research.

[57]  P. D. Webster,et al.  Experimental induction of pancreatic adenocarcinoma in rats. , 1975, Journal of the National Cancer Institute.

[58]  R. Ekholm,et al.  The ultrastructural organization of the rat exocrine pancreas: II. Centroacinar cells, intercalary and intralobular ducts , 1962 .

[59]  N. Clark,et al.  Direct Evidence , 1934 .